CN109134389A - The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids - Google Patents

The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids Download PDF

Info

Publication number
CN109134389A
CN109134389A CN201811104411.XA CN201811104411A CN109134389A CN 109134389 A CN109134389 A CN 109134389A CN 201811104411 A CN201811104411 A CN 201811104411A CN 109134389 A CN109134389 A CN 109134389A
Authority
CN
China
Prior art keywords
dicarboxylic acids
mixed solution
pyrazine dicarboxylic
sediment
purification process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811104411.XA
Other languages
Chinese (zh)
Inventor
吴贲华
高国忠
袁厚呈
黄浩
李海涛
张素梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Tiemao Glass Co Ltd
Original Assignee
Jiangsu Tiemao Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Tiemao Glass Co Ltd filed Critical Jiangsu Tiemao Glass Co Ltd
Priority to CN201811104411.XA priority Critical patent/CN109134389A/en
Publication of CN109134389A publication Critical patent/CN109134389A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

One kind 2, the purification process of 5- pyrazine dicarboxylic acids, include: weighing 2, 5- pyrazine dicarboxylic acids, it is placed in beaker, 2 are loaded with Ammonia addition, in the beaker of 5- pyrazine dicarboxylic acids, so that 2, 5- pyrazine dicarboxylic acids is completely dissolved, to obtain the first mixed solution, first mixed solution is separated by chromatographic column, to obtain the second mixed solution, third mixed solution is formed to the second mixed solution addition hydrochloric acid, and make its pH value 1, third mixed solution is stood, so that the sediment in third mixed solution starts to generate precipitating, third mixed solution is filtered, sediment is separated by third mixed solution, sediment is cleaned, to remove the hydrochloric acid remained on sediment and be cleaned using acetone to sediment, and the sediment after cleaning is dried, To obtain 2,5- pyrazine dicarboxylic acids after purification.A kind of 2,5- pyrazine dicarboxylic acids purified using purification process, the general formula with the structure as shown in formula (1):

Description

The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids
Technical field
The present invention is to be related to the purification process of one kind 2,5- pyrazine dicarboxylic acids, in particular to medicine intermediate or section Learn the purification process of the reagent of class research.
Background technique
2,5- pyrazine dicarboxylic acids (PYRAZINE-2,5-DICARBOXYLIC ACID) be all used to as medicine intermediate or It is the reagent for scientific research, impure more by 2, the 5- pyrazine dicarboxylic acids crude product bought on the market at present, product It is in yellow or brown, and the granular size of crystal is uneven more.However, either synthetic drug or as scientific research Reagent requires the good raw material or reagent of quality, and the purity of the accuracy or drug that can improve result of study is even The pharmacological property of drug is only held, therefore, containing too polymictic defect pole for presently commercially available 2,5- pyrazine dicarboxylic acids need find Suitable mode solves.
Summary of the invention
It is a primary object of the present invention to open one kind for commercially available 2,5- pyrazine dicarboxylic acids (PYRAZINE-2,5- DICARBOXYLIC ACID) purification process, contained impurity is removed in 2,5- pyrazine dicarboxylic acids using chromatography, is improved The problem of purity of 2,5- pyrazine dicarboxylic acids, solves in the prior art, and 2,5- pyrazine dicarboxylic acids contain impurity.
Another object of the present invention is to be purified for commercially available 2,5- pyrazine dicarboxylic acids, to control 2,5- pyrazine two The crystalline size size of carboxylic acid, solves in the prior art, the crystal size partial size of 2,5- pyrazine dicarboxylic acids problem bigger than normal.
Another object of the present invention is by obtained 2, the 5- pyrazine dicarboxylic acids of purification process disclosed in this invention, As the raw material sources of coating fluid, the advantage is that the light transmittance that can have height, thus can as large-scale window, and Visible rays field artificial adjustment light transmittance can also obstruct 99% or more ultraviolet light, delay taking off for furniture or fiber product The color time, and to the reflection characteristic near infrared ray field to indoor energy conservation 30% or more.
Another object of the present invention is to pass through obtained 2, the 5- pyrazine dicarboxylic acids of purification process disclosed in this invention, Because it can stop the characteristics such as ultraviolet light, adjusting visible rays light transmittance, reflection infrared ray, it can be used for the day of the various vehicles Window.Especially vehicle dormer window, to the light transmittance adjustable range of visible rays in 2-40%, to solar heat have it is effective stop it is special Property, pleasant driving environment is built to interior driver.
According to above-mentioned purpose, the present invention discloses the purification process of one kind 2,5- pyrazine dicarboxylic acids, includes: weighing 1000g's 2,5- pyrazine dicarboxylic acids are placed in beaker, with ammonium hydroxide (NH4OH) burning for being loaded with 2,5- pyrazine dicarboxylic acids is added in solution In cup, until 2,5- pyrazine dicarboxylic acids is dissolved completely in Ammonia, it is molten to obtain the first mixed solution, be mixed first Liquid is separated by chromatographic column, to obtain the second mixed solution, add hydrochloric acid to the second mixed solution to form third mixing Solution, hydrochloric acid addition is until the pH value of third mixed solution is 1, and is stirred simultaneously to third mixed solution, is mixed to third Solution left standstill is closed, so that the sediment in third mixed solution starts to generate precipitating, be filtered to third mixed solution, will be sunk Starch is separated by third mixed solution, is cleaned using the first clean solution to sediment, remains in precipitating to remove Hydrochloric acid on object and sediment is cleaned using the second clean solution, and the sediment after cleaning is dried, with The 2,5- pyrazine dicarboxylic acids purified.
According to the above, the present invention using chromatography by impurity by doing preliminary separation in 2,5- pyrazine dicarboxylic acids, then Remaining impurity acid is washed away using hydrochloric acid and is removed, by the available purity of way of purification disclosed in this invention higher 2,5- The purity and reliability of the drug of synthesis can be improved as medical intermediate, be used for as R&D institution for pyrazine dicarboxylic acids The accuracy of experimental data can be improved in the reagent of research experiment, solves in the prior art, 2, the 5- pyrazine two containing impurity Defect caused by carboxylic acid.
Detailed description of the invention
Fig. 1 is technology disclosed according to the present invention, indicates the step flow chart of 2,5- pyrazine dicarboxylic acids purification process.
Specific embodiment
In order to make the purpose of the present invention, technical characteristic and advantage, can more correlative technology field personnel understood, and be able to Implement the present invention, cooperates appended schema herein, specifically illustrates technical characteristic and embodiment of the invention, and enumerate preferable reality Apply example further explanation.It is not also needed with the schema hereinafter compareed to express signal related with feature of present invention It is completely drawn according to practical situation.And the technology well-known to those skilled in the art involved in the explanation of this case embodiment Content is also no longer stated.
The present invention proposes that the concept purified to 2,5- pyrazine dicarboxylic acids is primarily due to the 2,5- by obtaining on the market Pyrazine dicarboxylic acids is crude product, has the general formula of the structure as shown in formula (1):
And the crystal particle diameter size of commercially available 2,5- pyrazine dicarboxylic acids is uneven, and 2, the crystal color of 5- pyrazine dicarboxylic acids is presented Yellow or brown, with more impurity, if the purity of drug after composition is not yet as the raw material of synthetic drug Height, reliability reduce, and also influence drug quality;If or the reagent then 2,5- pyrazine dicarboxylic acids as R&D institution's experiment Impurity be easy influence experimental data accuracy.Therefore the present invention disclose a kind of utilization chromatography for 2,5- pyrazine dicarboxylic acids In impurity by being removed in 2,5- pyrazine dicarboxylic acids, and again penetrate pickling mode, remove remaining impurity, and can control The crystal particle diameter size for making 2,5- pyrazine dicarboxylic acids obtains 2, the 5- pyrazine dicarboxylic acids of purity is high, detailed purifying step whereby It is rapid as described below.
Please refer to Fig. 1.According to Fig. 1 disclosed herein technology, indicate 2,5- pyrazine dicarboxylic acids purification process step Rapid flow chart.Step 10: previously prepared concentration is the ammonium hydroxide (NH of 2N4OH) solution.In this step 10, by 3500ml's Distilled water pours into the flask of 4L, then the ammonium hydroxide that 500ml concentration is 25% is poured into the flask for being loaded with distilled water, mixes Uniformly, the ammonium hydroxide (NH that concentration is 2N is obtained4OH) solution, and the bottleneck of flask is sealed with plug, give subsequent step It is spare.
Step 12: weighing commercially available 2,5- pyrazine dicarboxylic acids weight 1000g and be placed in a beaker.
Step 14: the ammonium hydroxide (NH that will previously prepare, concentration is 2N4OH) solution, which pours into, is loaded with 2,5- pyrazine two In the beaker of carboxylic acid, until 2, the 5- pyrazine dicarboxylic acids in beaker is dissolved completely in Ammonia, and it is mixed to obtain first Close solution.In this step, chemical equation is as described under formula (2):
Wherein, the left side of formula (2) be by commercially available 2,5- pyrazine dicarboxylic acids and Ammonia hybrid reaction so that Carboxyl (the COO in carboxylic acid group (COOH) in 2,5- pyrazine dicarboxylic acids?) and ammonium ion (NH4 +) bond, and the hydrogen in carboxylic acid group Ion (H+) with Ammonia in hydroxide ion (OH?) bond generation water (H2O).Therefore, in the first mixed solution Main ingredient be formula (2) left side structure and water.
Then, step 16: the first mixed solution being chromatographed using chromatography to isolate in the first mixed solution Impurity.In step 16, the first mixed solution is subjected to chromatography by chromatography tubing string, it is molten in the first mixing to isolate Impurity in liquid, wherein the flow velocity of the mobile phase of chromatographic column is 10-20cc/min, and preferable flow velocity is 10cc/min.Specifically For, when 2,5- pyrazine dicarboxylic acids is dissolved completely in Ammonia, the impurity that 2,5- pyrazine dicarboxylic acids are had also can It is dissolved in Ammonia simultaneously, by chromatography, by impurity by being precipitated in the first mixed solution to obtain by separation Second mixed solution, in an embodiment of the present invention, the stationary phase of chromatographic column used in chromatography is active carbon, mobile phase the One mixed solution, i.e. 2,5- pyrazine dicarboxylic acids are dissolved completely in the mixed solution after Ammonia.
Then step 18: hydrochloric acid is added to the second mixed solution for having carried out chromatography and is stirred to form third mixing Solution, it is 1 i.e. stopping addition that wherein hydrochloric acid, which is added to the pH-value (pH value) of third mixed solution,.In step 18, salt is added The reaction equation such as formula (3) of acid to the second mixed solution for having been subjected to chromatography is described:
Wherein, during the left side of formula (3) is reacted with hydrochloric acid, solution can begin to change into milky, and hydrochloric acid (HCl) mentions Hydrogen ion (the H of confession+) can be with the carboxyl (COO in the chemical formula of left side?) combine, and ammonium ion (NH4 +) can with the chlorine in hydrochloric acid from Son (Cl?) combine, and be precipitated into chlorination ammonium salt (NH4Cl), so that foring 2,5- pyrazine dicarboxylic acids again in third mixed solution, Chemical formula i.e. on the right side of formula (3):But 2,5- pyrazine dicarboxylic acids at this time has been By product after purification.In addition, the concentration of added hydrochloric acid is 37% in this step.It therefore, can by above-mentioned reaction equation (3) To learn, the purpose for adding hydrochloric acid is will further to carry out pickling in the second mixed solution for having carried out chromatography, will Impurity is precipitated in the second mixed solution by having carried out chromatography, and (hydrochloric acid and has carried out in third mixed solution The mixed solution of second mixed solution of chromatography) in, further to purify 2,5- pyrazine dicarboxylic acids, furthermore penetrate hydrochloric acid The step of addition, can control the crystal particle diameter size of 2,5- pyrazine dicarboxylic acids.
Following step 20: third mixed solution is stood, and is sunk so that the sediment in third mixed solution starts to generate It forms sediment, in this step 20, the time of standing is 10-16 hours, and preferable time of repose is 12 hours.
Step 22: third mixed solution being filtered, sediment is separated by third mixed solution.When third is mixed Close and begin with crystal and generate precipitating by being precipitated in third mixed solution after solution left standstill, at this time in order to by sediment by the It is separated in three mixed solutions, is reached using funnel especially Buchner funnel, sediment is filtered out and comes and is placed in On Buchner funnel, filtrate (i.e. third mixed solution) can be contained in clean beaker.In this step, in order to ensure all Sediment can be filtered out by third mixed solution Lai can be duplicate by filtered filtrate (third mixed solution) It is filtered by funnel.
Step 24: sediment being cleaned using the first clean solution, to remove the hydrochloric acid remained on sediment.In In this step, using the first clean solution such as distilled water, the especially distilled water of ice, temperature is -5 DEG C, for filtering out and holding The sediment being placed on funnel is cleaned, and is filtered.The purpose of this step is, the hydrochloric acid that will remain on sediment Removing is cleaned, and clean number does not limit.In an embodiment of the present invention, since 2,5- pyrazine dicarboxylic acids has centainly Water solubility, step 24 be added ice distilled water be in order to preferably by Precipitation.
Then step 26: sediment is cleaned using the second clean solution, and the sediment after cleaning is done It is dry, with 2, the 5- pyrazine dicarboxylic acids purified.Step 26 is the later progress of and then step 24, utilizes the second clean solution Such as acetone, it is poured on the step of sediment being placed on funnel does further cleaning, and similarly filtered, cleaned Number can be 2-6 times, but do not limit, at least 4 times in general practical operation, cleaning for the first time and clean for second, And filtered, and third time and the 4th cleaning, it is drained after filtering, by the sediment after filtering and tentatively draining 2, the 5- pyrazine dicarboxylic acids that can be obtained after purification is dried, it is identical as formula (1) with general formula,
And after above-mentioned step 26 is using the second clean solution cleaning sediment, it can also include giving sediment Stand, the upper end of funnel is covered in using filter paper, allow the acetone as the second clean solution to be volatilized and by sediment It removes.
Finally, will it is dry after and purified 2,5- pyrazine dicarboxylic acids be directly placed into storage bottle and stored or used Storage bottle is put into after Yan Portland grinding to be stored.
In addition, can be applied to for utilizing obtained 2, the 5- pyrazine dicarboxylic acids of purification process disclosed in this invention Coating fluid, since the crystal color of purified 2,5- pyrazine dicarboxylic acids is blue, when as coating fluid, with height Light transmittance.Therefore, 2, the 5- pyrazine dicarboxylic acids obtained using purification process disclosed in this invention can be made into large-scale window, excellent Point is: 1, the curtain that can be replaced protection privacy, obstruct solar heat, so can also be used as building materials window.It can be in visible rays Field artificial adjustment light transmittance can also obstruct 99% or more ultraviolet light, can delay the fading time of furniture or fiber product, and And to the reflection characteristic near infrared ray field to indoor energy conservation 30% or more.2, the product is because of its blocking ultraviolet light, tune The characteristics such as visible rays light transmittance, reflection infrared ray are saved, can be used for the skylight of the various vehicles.Especially vehicle dormer window, it is right The light transmittance adjustable range of visible rays has effective barrier properties in 2-40%, to solar heat, to interior driver battalion Make pleasant driving environment.
According to the above, the present invention using chromatography by impurity by doing preliminary separation in 2,5- pyrazine dicarboxylic acids, then Remaining impurity acid is washed away using hydrochloric acid and is removed, by the available purity of way of purification disclosed in this invention higher 2,5- The purity and reliability of the drug of synthesis can be improved as medical intermediate, be used for as R&D institution for pyrazine dicarboxylic acids The accuracy of experimental data can be improved in the reagent of research experiment, solves in the prior art, 2, the 5- pyrazine two containing impurity Defect caused by carboxylic acid.
The foregoing is merely the preferred embodiments of the invention, the interest field that is not intended to limit the invention;More than simultaneously Description, the special personage of correlative technology field should can be illustrated and be implemented, thus other without departing from it is disclosed it The lower equivalent change or modification completed of spirit, should be included in claim.

Claims (10)

1. one kind 2, the purification process of 5- pyrazine dicarboxylic acids, which is characterized in that the purification process packet of 2, the 5- pyrazine dicarboxylic acids Include following steps:
(1) 2, the 5- pyrazine dicarboxylic acids for weighing 1000g, is placed in beaker;
(2) ammonium hydroxide (NH is used4OH) solution addition is loaded in the beaker of 2, the 5- pyrazine dicarboxylic acids, until described 2,5- pyrazine dicarboxylic acids are dissolved completely in the Ammonia, to obtain the first mixed solution;
(3) first mixed solution is separated by chromatographic column, to obtain the second mixed solution;
(4) hydrochloric acid is added to second mixed solution to form third mixed solution, the hydrochloric acid addition is until the third The pH value of mixed solution is 1, and is stirred simultaneously to the third mixed solution;
(5) the third mixed solution is stood, so that the sediment in the third mixed solution starts to generate precipitating;
(6) the third mixed solution is filtered, the sediment is separated by the third mixed solution;
(7) sediment is cleaned using the first clean solution, to remove the salt remained on the sediment Acid;And
(8) sediment is cleaned using the second clean solution, and the sediment after cleaning is dried, with The 2,5- pyrazine dicarboxylic acids purified.
2. the purification process of 2,5- pyrazine dicarboxylic acids as described in claim 1, which is characterized in that the stationary phase of the chromatographic column It can be active carbon.
3. the purification process of 2,5- pyrazine dicarboxylic acids as described in claim 1, which is characterized in that the mobile phase of the chromatographic column It can be first mixed solution.
4. the purification process of 2,5- pyrazine dicarboxylic acids as claimed in claim 3, which is characterized in that the stream of the chromatographic column The flow velocity of dynamic phase is 10-20cc/min.
5. the purification process of 2,5- pyrazine dicarboxylic acids as described in claim 1, which is characterized in that the third mixed solution Time of repose is 10-15 hours.
6. the purification process of 2,5- pyrazine dicarboxylic acids as described in claim 1, which is characterized in that the first clean solution is Distilled water.
7. the purification process of 2,5- pyrazine dicarboxylic acids as described in claim 1, which is characterized in that the second clean solution is Acetone.
8. the purification process of 2,5- pyrazine dicarboxylic acids as described in claim 1, which is characterized in that cleaned using described second molten It is 2-6 times that liquid, which carries out wash number to the sediment,.
9. the purification process of 2,5- pyrazine dicarboxylic acids as described in claim 1, which is characterized in that described in being utilized in step (7) Second clean solution allows to further including the sediment after cleaning after the sediment and between step (8) and stood The second clean solution evaporation and remove.
10. 2,5- pyrazine two prepared by a kind of purification process using 2,5- pyrazine dicarboxylic acids as claimed in claims 1-9 Carboxylic acid, the general formula with the structure as shown in formula (1):
CN201811104411.XA 2018-09-21 2018-09-21 The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids Pending CN109134389A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811104411.XA CN109134389A (en) 2018-09-21 2018-09-21 The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811104411.XA CN109134389A (en) 2018-09-21 2018-09-21 The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids

Publications (1)

Publication Number Publication Date
CN109134389A true CN109134389A (en) 2019-01-04

Family

ID=64815466

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811104411.XA Pending CN109134389A (en) 2018-09-21 2018-09-21 The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids

Country Status (1)

Country Link
CN (1) CN109134389A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111689910A (en) * 2020-06-19 2020-09-22 江苏铁锚玻璃股份有限公司 Method for removing impurity iodine in pyrazine compound
CN114394943A (en) * 2022-01-04 2022-04-26 江苏铁锚玻璃股份有限公司 Method for purifying insoluble solid dicarboxylic acid
CN115403529A (en) * 2022-09-26 2022-11-29 济南悟通生物科技有限公司 Purification method of 2, 5-pyrazine dicarboxylic acid by-product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871736A (en) * 1986-11-25 1989-10-03 The Ohio State University Stereoisomeric tricyclic bis(dioxopiperazines) and pharmaceutical compositions
JP2018090531A (en) * 2016-12-02 2018-06-14 日立化成テクノサービス株式会社 Method for producing heteroaromatic carboxylic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871736A (en) * 1986-11-25 1989-10-03 The Ohio State University Stereoisomeric tricyclic bis(dioxopiperazines) and pharmaceutical compositions
JP2018090531A (en) * 2016-12-02 2018-06-14 日立化成テクノサービス株式会社 Method for producing heteroaromatic carboxylic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
W. J. SCHUT ET AL.: "INVESTIGATIONS ON PYRAZINE DERIVATIVES. VII On the conversion of pyrazine 2,5-dicarboxylic acid into some derivatives of 2-aminopyrazine 5-carboxylic acid", 《RECUEIL》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111689910A (en) * 2020-06-19 2020-09-22 江苏铁锚玻璃股份有限公司 Method for removing impurity iodine in pyrazine compound
CN111689910B (en) * 2020-06-19 2022-03-08 江苏铁锚玻璃股份有限公司 Method for removing impurity iodine in pyrazine compound
CN114394943A (en) * 2022-01-04 2022-04-26 江苏铁锚玻璃股份有限公司 Method for purifying insoluble solid dicarboxylic acid
CN115403529A (en) * 2022-09-26 2022-11-29 济南悟通生物科技有限公司 Purification method of 2, 5-pyrazine dicarboxylic acid by-product
CN115403529B (en) * 2022-09-26 2023-06-13 济南悟通生物科技有限公司 Purification method of 2, 5-pyrazine dicarboxylic acid byproduct

Similar Documents

Publication Publication Date Title
CN109134389A (en) The purification process of 2,5- pyrazine dicarboxylic acids and obtained 2,5- pyrazine dicarboxylic acids
CA1204738A (en) Process for purifying anthracyclinonic glycosides by selective adsorption on resins
CN102617607B (en) Method for preparing cefazolin compounds
CN105198762B (en) Enzymatic lysis method produces the comprehensive recovering process of effective ingredient in 7-amino-cephalosporanic acid crystalline mother solution
CN101584671A (en) Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium
CN106478600B (en) A kind of refining methd of Lansoprazole
CN102796120A (en) Method for preparing cefaclor
CN109575048B (en) Preparation method of cefotaxime sodium
CN105131017A (en) Preparation method for cefcapene pivoxil hydrochloride
CN104892636B (en) A kind of method for preparing CTX sodium crystal
CN102153566B (en) Method for preparing cefdinir
JP2001064010A (en) Synthetic method of tubular aluminum silicate from high concentration inorganic solution
CN103360412B (en) A kind of synthetic method of S 578
CN104277053B (en) A kind of preparation method of Cefodizime and its intermediate cefodizime acid
CN105238841B (en) Cephalosporin adsorbs the recycling of DCPC and method for transformation in waste liquid
CN110194459B (en) Preparation method of silica gel with large pore volume and high specific surface area
CN102391288B (en) Preparation methods of cefpirome intermediate and cefpirome
US4308375A (en) Method for purifying water-insoluble polyene antibiotics
CN107266473A (en) A kind of synthetic method of cefotaxime
CN106478666B (en) The preparation method of 7- amino -3- methoxyl methyl -3- cephem -4- carboxylic acids
CN108033971A (en) A kind of synthetic method of Method of cefcapene pivoxil hydrochloride
CN101607893B (en) Method for obtaining pharmaceutical-grade citric acid from food-grade citric acid
DE2502097A1 (en) METHOD FOR CLEANING UP CEPHALOSPORINES
CN112642405B (en) Recyclable adsorbent and preparation method and application thereof
JPS624399B2 (en)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190104